This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Brokers Suggest Investing in Vital Farms (VITL): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Vital Farms (VITL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Boston Beer Introduces a Line of Alcohol-Free Cannabis Cocktails
by Zacks Equity Research
SAM launches Emerald Hour, a new lineup of non-alcoholic Cali Sober cannabis cocktails.
Keurig Dr Pepper's Strategic Efforts Seem Encouraging: Apt to Hold?
by Zacks Equity Research
KDP gains from innovation and a solid performance in its Refreshment Beverages segment.
Colgate Gains 21.3% YTD: What Makes the Stock Apt to Retain?
by Zacks Equity Research
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
STZ to Divest SVEDKA Label to Reshape Its Wine & Spirits Portfolio
by Zacks Equity Research
Constellation Brands reshapes its wine and spirits portfolio. The company agrees to divest its SVEDKA brand.
Clorox's Pricing & Cost-Saving Efforts Bode Well: Apt to Hold the Stock
by Zacks Equity Research
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Newell's Innovations & Other Strategies Seem Encouraging: Apt to Hold
by Zacks Equity Research
NWL's strategic endeavors, including organizational realignment and cost-saving efforts, bode well.
PepsiCo Agrees to Buy the Remaining 50% Stake in Sabra and Obela
by Zacks Equity Research
PEP agrees to fully acquire Sabra and Obela. The company is focused on boosting greater efficiency by reducing costs.
Are Options Traders Betting on a Big Move in Vital Farms (VITL) Stock?
by Zacks Equity Research
Investors need to pay close attention to Vital Farms (VITL) stock based on the movements in the options market lately.
AB InBev Invests $14M in Houston Brewery to Boost Beer Production
by Zacks Equity Research
BUD invests $14 million in its Houston brewery. Pricing actions, ongoing premiumization and other revenue-management initiatives have been drivers.
CTVA Announces Financial Framework & New $3-B Share Repurchase Plan
by Zacks Equity Research
Corteva highlights its financial framework through 2027. The company approves a new $3-billion share repurchase authorization.
MNST's Strength in Energy Drinks & Innovation Bodes Well: Apt to Hold
by Zacks Equity Research
Monster Beverage gains from strength in its energy drinks category and product innovations. The company benefits from its pricing actions.
Archer Daniels' Q3 Earnings Lag Estimates, Revenues Decline 8.1% Y/Y
by Zacks Equity Research
ADM reports lower revenues year over year in third-quarter 2024 owing to a decline in sales across most of its segments.
Diageo Introduces Luxury Group Division to Enrich Experience
by Zacks Equity Research
DEO benefits from its focus on improving productivity coupled with its diversified footprint. Its single new global division, Diageo Luxury Group, is set to offer luxury spirits.
TreeHouse Foods Q3 Earnings Meet, View Cut on Weak Consumption Trends
by Zacks Equity Research
THS Q3 results show top-line pressures from the voluntary griddle recall and lower volume/mix, with significant margin improvements and y/y bottom-line growth.
CL's Pricing & Productivity Efforts Bode Well: Apt to Hold the Stock?
by Zacks Equity Research
Colgate benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
3 Reasons Why Growth Investors Shouldn't Overlook Vital Farms (VITL)
by Zacks Equity Research
Vital Farms (VITL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Tyson Foods' Q4 Earnings Top, Operating Income More Than Doubles
by Zacks Equity Research
TSN's results reflect a solid enhancement in profitability for the fourth quarter and the full year. The company is well-positioned for fiscal 2025.
MKC's Flavorful Growth Journey: Strategic Efforts Fuel Momentum
by Zacks Equity Research
McCormick has positioned itself well to navigate challenging macroeconomic conditions and continue its recovery in volume growth across key regions.
Molson Coors Rises 5% Post Q3 Earnings: Buy, Hold or Avoid the Stock?
by Zacks Equity Research
TAP makes significant progress with the Acceleration Plan. The company's revitalization plan and the premiumization of the global portfolio also bode well.
Vital Farms Q3 Earnings Beat Estimates on Higher Sales & Gross Margin
by Zacks Equity Research
VITL Q3 results reflect robust sales momentum driven by higher volumes and favorable pricing, supported by its focus on ethical food production.
Monster Beverage Q3 Earnings & Sales Miss on Soft Energy Drink Segment
by Zacks Equity Research
MNST's Q3 results reflect soft energy drink growth in the United States, along with currency impacts and rising operating expenses that affected sales and margins.
Is Brown-Forman Stock a Buy, Sell or Hold at a P/E Multiple of 22.4x?
by Zacks Equity Research
BF.B's premiumization strategy and global expansion efforts position it for long-term growth, though near-term headwinds remain a concern.
Molson Coors Q3 Earnings & Sales Beat, Stock Dips on Soft View
by Zacks Equity Research
A challenging U.S. macroeconomic environment, leading to lower financial volumes, mars TAP's Q3 results. The EMEA&APAC and Canada units have been strong.
HSY Down on Q3 Earnings Miss, View Cut Amid Weak Consumer Trends
by Zacks Equity Research
The Hershey Company's Q3 results reflect lower net sales and earnings amid a challenging consumer environment and high cocoa prices.